OR

Oramed Pharmaceuticals

- NASDAQ:ORMP
Last Updated 2024-04-16
  • Oramed Pharmaceuticals develops proprietary Protein Oral Delivery technology for the delivery of drugs.

  • Locations

    • Jerusalem Yerushalayim

  • Total Funding (USD)

    4.0 million

  • Industries

    Internet, Mobile Apps, Video Games, Software, Cyber Security

  • Security

    Type: ORD
    CUSIP: 68403P203
    ISIN: US68403P2039
Filter date
All
Bookmark Created by Last updated
There were no results found.
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.

Request Demo